Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma

NCT05078853

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +17 more
Locations
  • Barzilai Medical Center Ashkelon, Israel
  • Soroka University Medical Center Beersheba, Israel
  • Hebrew University Medical Center, Mount Scopus Jerusalem, Israel
  • Sheba Medical Center Ramat Gan, Israel
View Trial Details
Completed

Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer

NCT05219435

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Hospital Universitario Juan Ramón Jiménez Huelva, Andalusia, Spain
  • Hospital Universitario Virgen de la Macarena Seville, Andalusia, Spain
  • Hospital Clínico Universitario de Zaragoza Zaragoza, Aragon, Spain
  • Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
View Trial Details
Completed

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

NCT04095208

Conditions
Advanced Cancer, Neoplasm Metastasis, Neoplasms, +9 more
Locations
  • Institut Bergonié Bordeaux, France
  • Centre Léon Bérard Lyon, France
  • Institut de Cancérologie de l'Ouest - Site René Gauducheau Nantes, France
  • Hôpital Cochin Paris, France
View Trial Details
Completed

AZD9291 First Time In Patients Ascending Dose Study

NCT01802632

Conditions
Advanced (Inoperable) Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, +13 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

NCT03881488

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • Ocala Oncology Center Ocala, Florida, United States
  • Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

NCT01298323

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations
  • Investigational Site Number : 301 St Leonards, New South Wales, Australia
  • Investigational Site Number 301 St Leonards, Australia
  • Investigational Site Number 401 Vienna, Austria
  • Investigational Site Number : 401 Vienna, Austria
View all 66 locations
View Trial Details
Completed

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

NCT01630733

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University Cancer Institute Boynton Beach, Florida, United States
  • Florida Hospital Orlando, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Joliet Oncology-Hematology Associates Ltd. Joliet, Illinois, United States
View all 78 locations
View Trial Details

Related conditions